Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2005
11/16/2005EP1594981A2 Double ended sequencing
11/16/2005EP1594980A2 Bead emulsion nucleic acid amplification
11/16/2005EP1594975A2 Multiplex amplification of polynucleotides
11/16/2005EP1594964A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
11/16/2005EP1594955A2 An expression cassette and vector for transient or stable expression of exogenous molecules
11/16/2005EP1594954A2 Directed genetic modifications of human stem cells
11/16/2005EP1594950A2 Method for preparing single-stranded dna libraries
11/16/2005EP1594694A2 Methods and apparatus for pathogen detection and analysis
11/16/2005EP1594530A2 Albumin fusion proteins
11/16/2005EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
11/16/2005EP1594432A2 Short immunomodulatory oligonucleotides
11/16/2005EP1438429A4 Nucleic acids for the identification of fungi and methods for using the same
11/16/2005EP1392868A4 Method for the synthesis of dna sequences
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP0741745B1 Hepatitis b vaccine
11/16/2005EP0651811B1 K. lactis rp28 ribosomal protein gene promoter and use thereof
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/15/2005US6965041 N-acylphosphoramidites and their use in oligonucleotide synthesis
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965020 Nucleic acid labeling compounds
11/15/2005US6965012 Flint polypeptide analogs
11/15/2005US6964847 Derivative nucleic acids and uses thereof
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964765 Hybrid nucleic acid; isolation antibody
11/15/2005CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/15/2005CA2172534C Conformationally locked nucleoside analogues
11/10/2005WO2005106044A1 Compositions and methods for breast cancer prognosis
11/10/2005WO2005106043A2 Breast cancer gene expression biomarkers
11/10/2005WO2005106035A2 Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use
11/10/2005WO2005106011A2 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005WO2005106009A2 Lactoferrin cleavage of neisserial proteins
11/10/2005WO2005105995A2 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/10/2005WO2005105142A2 Recombinant reverse transcriptases
11/10/2005WO2005087810A3 Dimeric fusion proteins and materials and methods for producing them
11/10/2005WO2005084210A3 Multiplex detection probes
11/10/2005WO2005082932A3 Compositions and methods using rna interference for control of nematodes in plants
11/10/2005WO2005064018A3 Microwave mediated synthesis of nucleic acid probes
11/10/2005WO2005014779A3 Cyclodextrin affinity purification
11/10/2005WO2005010203A3 Treatment of cells for fluorescence in situ hybridization
11/10/2005WO2004104212A3 Molecular signature and assay for fluoroquinoline resistance in bacillus anthracis
11/10/2005WO2004094345A3 Protected monomers
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005WO2004064482A3 Alien sequences
11/10/2005WO2004029283A3 Subtelomeric dna probes and method of producing the same
11/10/2005US20050251883 Dwarfism genes and dwarf plants
11/10/2005US20050251882 Sucrose phosphate synthase nucleic acid molecules and uses therefor
11/10/2005US20050251875 Transgenic plants with tocopherol methyltransferase
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050250933 Vaccines
11/10/2005US20050250722 FcgammaRIIA-specific nucleic acid interference
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors
11/10/2005US20050250695 Combination PDGF, KGF, IGF, and IGFBP for wound healing
11/10/2005US20050250185 OGH fusion polypeptides and therapeutic uses thereof
11/10/2005US20050250182 Novel genes, compositions, and methods for modulating the unfolded protein response
11/10/2005US20050250181 Cell-wall degrading enzyme variants
11/10/2005US20050250180 Secreted protein and polynucleotides encoding them
11/10/2005US20050250154 Peptides associated with hepsin protease active site for use in identification of modulators for treatment of cell proliferative disorders
11/10/2005US20050250149 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
11/10/2005US20050250137 Molecular targets of cancer and aging
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250135 Nucleic acid encoding a polypeptide having histidine kinase activity; plasmids and host cells; engineering microorganisms, including Lactobacillus acidophilus, to have an increased ability to tolerate various stress conditions; probiotics
11/10/2005US20050250134 Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
11/10/2005US20050250132 Real-time polymerase chain reaction-based genotyping assay for chemokine receptor (CXCR2) single nucleotide polymorphism
11/10/2005US20050250129 Apparatus and method for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber
11/10/2005US20050250128 Membranes incorporating recognition moieties
11/10/2005US20050250126 Ztnf13, a tumor necrosis factor
11/10/2005US20050250123 Reducing galectin-12 activity to reduce formation of adipocytes
11/10/2005US20050250119 Fluorescent nucleobase conjugates having anionic linkers
11/10/2005US20050250118 EPHX2 Genetic markers associated with galantamine
11/10/2005US20050250116 Universal supports for oligonucleotide synthesis
11/10/2005US20050250112 Nucleic acids, compositions, methods, and kits for detecting mycoplasma and acholeplasma species
11/10/2005US20050250106 Gene knock-down by intracellular expression of aptamers
11/10/2005US20050250101 Method for identifying vehicle and oligonucleotide marker used therefor
11/10/2005US20050249789 Alpha/beta hydrolase-fold enzymes
11/10/2005US20050249786 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
11/10/2005US20050249748 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/10/2005US20050249743 Isolated peptides which bind to HLA-A24 molecules and uses thereof
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249726 Useful as therapeutic agent and diagnostic tool for brain tumors which strongly express antigen that is recognized by this antibody
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050247001 Building block forming a c-c or a c-hetero atom bond uponreaction
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563903A1 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005CA2557532A1 Inhibition of hairless protein mrna
11/10/2005CA2551842A1 Method of identifying hairpin dna probes by partial fold analysis
11/09/2005EP1593425A1 Preparation method and use of micro-arrays supports for detection of multiple polynucleotide sequences with high sensitivity
11/09/2005EP1592799A2 Annexin and p34 promoters and use in expression of transgenic genes in plants
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592702A2 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
11/09/2005EP1546327A4 Selection and isolation of living cells using rna-binding probes
11/09/2005EP1285065B1 Long wavelength engineered fluorescent proteins
11/09/2005EP1056758B1 Electrophoretic nucleic acid purification method
11/09/2005EP0928290B9 Oligoribonucleotides and ribonucleases for cleaving rna
11/09/2005EP0760857B1 Receptor for oncostatin m
11/09/2005EP0753068B1 Ligands added to adenovirus fiber
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 899